BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20304824)

  • 1. Soluble IL-7R alpha (sCD127) inhibits IL-7 activity and is increased in HIV infection.
    Crawley AM; Faucher S; Angel JB
    J Immunol; 2010 May; 184(9):4679-87. PubMed ID: 20304824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
    Vranjkovic A; Crawley AM; Patey A; Angel JB
    J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
    Faller E; Kakal J; Kumar R; Macpherson P
    Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 induces sCD127 release and mCD127 downregulation in human CD8
    Côté SC; Burke Schinkel SC; Berthoud TK; Barros PO; Sanchez-Vidales M; Davidson AM; Crawley AM; Angel JB
    Eur J Immunol; 2020 Oct; 50(10):1537-1549. PubMed ID: 32390135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 decreases IL-7 receptor alpha (CD127) expression and induces the shedding of CD127 by human CD8+ T cells.
    Vranjkovic A; Crawley AM; Gee K; Kumar A; Angel JB
    Int Immunol; 2007 Dec; 19(12):1329-39. PubMed ID: 17956896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.
    Crawley AM; Vranjkovic A; Young C; Angel JB
    Eur J Immunol; 2010 May; 40(5):1396-407. PubMed ID: 20201040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of HIV on CD127 expression and its potential implications for IL-7 therapy.
    Crawley AM; Angel JB
    Semin Immunol; 2012 Jun; 24(3):231-40. PubMed ID: 22421574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
    Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
    Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.
    Sasson SC; Zaunders JJ; Zanetti G; King EM; Merlin KM; Smith DE; Stanley KK; Cooper DA; Kelleher AD
    J Infect Dis; 2006 Feb; 193(4):505-14. PubMed ID: 16425129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A validated assay to measure soluble IL-7 receptor shows minimal impact of IL-7 treatment.
    Janot-Sardet C; Assouline B; Cheynier R; Morre M; Beq S
    J Immunol Methods; 2010 Feb; 353(1-2):115-23. PubMed ID: 20035760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased soluble IL-7 receptor concentrations associate with improved IL-7 therapy outcomes in SIV-infected ART-treated Rhesus macaques.
    Steele AK; Carrasco-Medina L; Sodora DL; Crawley AM
    PLoS One; 2017; 12(12):e0188427. PubMed ID: 29261677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a quantitative bead capture assay for soluble IL-7 receptor alpha in human plasma.
    Faucher S; Crawley AM; Decker W; Sherring A; Bogdanovic D; Ding T; Bergeron M; Angel JB; Sandstrom P
    PLoS One; 2009 Aug; 4(8):e6690. PubMed ID: 19690616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced IL-7R T Cell Expression and Increased Plasma sCD127 in Late Presenting HIV-Infected Individuals.
    Hartling HJ; Jespersen S; Gaardbo JC; Sambleben C; Thorsteinsson K; Gerstoft J; Ullum H; Nielsen SD
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):81-90. PubMed ID: 27509242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
    Marchetti G; Meroni L; Molteni C; Taskaris G; Gazzola L; Galli M; Clerici M; Moroni M; Franzetti F; Gori A
    Antivir Ther; 2004 Jun; 9(3):447-52. PubMed ID: 15259908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between levels of IL-7Ralpha expression and responsiveness to IL-7 is lost in CD4 lymphocytes from HIV-infected patients.
    Colle JH; Moreau JL; Fontanet A; Lambotte O; Delfraissy JF; Thèze J
    AIDS; 2007 Jan; 21(1):101-3. PubMed ID: 17148974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection.
    Zhang SY; Zhang Z; Fu JL; Kang FB; Xu XS; Nie WM; Zhou CB; Zhao M; Wang FS
    Eur J Immunol; 2009 May; 39(5):1425-34. PubMed ID: 19350559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyclonal proliferation and apoptosis of CCR5+ T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2.
    Zaunders JJ; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher A; Cooper DA; Smith DE; Grey P; Estaquier J; Little S; Richman DD; Corbeil J
    J Infect Dis; 2003 Jun; 187(11):1735-47. PubMed ID: 12751031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection.
    Carini C; McLane MF; Mayer KH; Essex M
    Eur J Immunol; 1994 Dec; 24(12):2927-34. PubMed ID: 7805718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.
    Boudet F; Lecoeur H; Gougeon ML
    J Immunol; 1996 Mar; 156(6):2282-93. PubMed ID: 8690919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.